Klein Joseph III's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jul 6, 2026
- Accession no.
- 0000874015-26-000229
- Filed
- Jul 6, 2026, 6:49 PM ET
- Trade date
- Jul 1, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $910.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Joseph IIICIK 0001206369 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | MOption exerciseAcquired | +11,518 | $39.94 | +$460,028.92 | 22,532 | Direct | |
| Jul 1, 2026 | Common Stock | SSaleDisposed | −99 | $79.45 | −$7,865.55 | 22,433 | Direct | |
| Jul 1, 2026 | Common Stock | SSaleDisposed | −11,419 | $79.04 | −$902,550.91 | 11,014 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | MOption exerciseDisposed | −11,518 | $0.00 | $0 | 0 | Direct | |
| Jul 1, 2026 | Common Stock | AGrant or awardAcquired | +5,369 | $0.00 | $0 | 5,369 | Direct | |
| Jul 1, 2026 | Common Stock | AGrant or awardAcquired | +2,301 | $0.00 | $0 | 16,277 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.